tirzepatide Semaglutide is the active ingredient in Ozempic and Wegovy
BCL-2 family proteins: changing partners in the dance towards death
Semaglutide is a GLP-1 receptor agonist administered weekly for weight management in adults with obesity or overweight with comorbidities
[53] In the other three trials (NCT3987919, NCT03882970, and NCT03730662), participants were randomly assigned to receive either tirzepatide or another antidiabetic medication, and both the patient and the provider knew which medication was being given
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial
In the gastrointestinal tract, the peptide has been shown to protect mucosal integrity against damage caused by ethanol, non-steroidal anti-inflammatory drugs (NSAIDs), aspirin, and various other chemical insults in rat models